scholarly journals Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting

Eye ◽  
2013 ◽  
Vol 27 (5) ◽  
pp. 657-662 ◽  
Author(s):  
S Basu ◽  
S Nayak ◽  
T R Padhi ◽  
T Das
2016 ◽  
Vol 25 (1) ◽  
pp. 97-104 ◽  
Author(s):  
Rupesh Agrawal ◽  
Bhaskar Gupta ◽  
Julio J. González-López ◽  
João Cardoso ◽  
Ioanna Triantafullopoulou ◽  
...  

2015 ◽  
Vol 23 (1) ◽  
pp. 40-46 ◽  
Author(s):  
Rupesh Agrawal ◽  
Bhaskar Gupta ◽  
Julio J. Gonzalez-Lopez ◽  
Farzana Rahman ◽  
Sumita Phatak ◽  
...  

2019 ◽  
Vol 9 (2) ◽  
pp. 127 ◽  
Author(s):  
De-Kuang Hwang ◽  
Te-An Wang ◽  
Kang-Jung Lo ◽  
Shih-Jen Chen

2018 ◽  
Vol 14 (9) ◽  
pp. 122
Author(s):  
Samia Nassik ◽  
Aouatef Masmoudi ◽  
Salssabile Nafizy ◽  
Saad Mouine ◽  
Amine Kouisbahi ◽  
...  

Introduction: The ophthalmological manifestation of tuberculosis varies significantly, and almost all the elements of the globe and orbit can be reached. Methods and Results: The aim of this work was to report a clinical aspect of ocular tuberculosis in a young woman who has a notion of tuberculous contagion and who was presented at the fundus of a macular papillary membrane with a tubercle of Bouchut or papillary tubercle. The diagnosis was retained on a bundle of clinical, biological, and radiological arguments. The evolution under treatment was favorable with an improvement of its visual acuity. Conclusion: It is necessary to know how to evoke the tuberculous etiology in view of all ocular inflammation, even atypical. This is required considering the great polymorphism of its clinical characteristics.


2010 ◽  
Vol 55 (1) ◽  
pp. 16 ◽  
Author(s):  
BMGD Yasaratne ◽  
D Madegedara ◽  
NS Senanayake ◽  
T Senaratne

2021 ◽  
pp. 112067212110446
Author(s):  
Yuslay Fernández Zamora ◽  
Luciana Peixoto Finamor ◽  
Luci Meire P Silva ◽  
Denise S Rodrigues ◽  
Ricardo P Casaroli-Marano ◽  
...  

Purpose: To evaluate the clinical features and management of presumed ocular tuberculosis (OTB). Method: A prospective 3-year follow-up study of patients with ocular inflammation that performed Interferon-gamma release assay (IGRA) and tuberculin skin test (TST) was conducted in a tertiary referral center in Brazil. Patients with clinical signs highly suspect of OTB with a positive TST and/or IGRA with other causes ruled out were prescribed anti-tuberculosis therapy (ATT) during 9 months. Clinical features and treatment outcomes were recorded. Results: Seventy-two patients (mean age 48.3 ± 15.7 years) were included in the study, and most were female (65.3%, n = 47). Posterior uveitis (43.1%, n = 31) was the main clinical feature. Multifocal choroiditis (25%, n = 18) was the most common choroidal involvement. Concomitant oral prednisone (45.8%, n = 33) during ATT was associated with more recurrences ( p = 0.04). A significant difference ( p < 0.001) between initial and final best-corrected visual acuity after ATT conclusion was observed. Cure or remission was observed in 58 (85.3%) patients that completed follow-up ( n = 68). Conclusion: In our cohort some variation in demographics and ocular phenotypes of presumed OTB was observed. The high rates of cure or remission of our patients strongly support the ATT in presumed OTB. Oral corticosteroids during ATT were associated with higher recurrences rates.


Sign in / Sign up

Export Citation Format

Share Document